| Literature DB >> 19763519 |
S Boneberger1, R A Rupec, T Ruzicka.
Abstract
Hydroxyurea is frequently used for therapy of myeloproliferative disorders. One cutaneous side-effect is painful, therapy-resistant ulcers which have bizarre configurations and occur at atypical sites for venous ulcers. Improvement or healing often first occurs when hydroxyurea is discontinued. We report on one patient with essential thrombocythemia and two with polycythemia vera, who developed such ulcers during hydroxyurea therapy. In one case, the ulcers developed shortly after hydroxyurea was started. In addition we give a short overview of the current literature.Entities:
Mesh:
Substances:
Year: 2010 PMID: 19763519 DOI: 10.1007/s00105-009-1794-1
Source DB: PubMed Journal: Hautarzt ISSN: 0017-8470 Impact factor: 0.751